KunWha Pharmaceutical Co., Ltd. (KOSE:A002250) has been chosen as the preferred bidder to buy Hanwha Corp.'s (KOSE:A000880) Dream Pharma Corp., according to sources on July 3, 2014. Kunwha Pharmaceuticals will exercise its right to enter into exclusive negotiations for two weeks.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
26,650 KRW | +0.38% | -2.91% | +3.50% |
May. 16 | White House moves to protect US solar manufacturers from Chinese competition | RE |
Apr. 24 | US solar panel makers seek new tariffs to protect domestic factories | RE |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+3.50% | 1.46B | |
+14.45% | 80.65B | |
+10.22% | 51.83B | |
+6.29% | 49.83B | |
+24.11% | 47.95B | |
+24.78% | 40.19B | |
+2.40% | 30.05B | |
-2.49% | 29.32B | |
-9.24% | 28.03B | |
+22.40% | 25.46B |
- Stock Market
- Equities
- A000880 Stock
- News Hanwha Corporation
- Kunwha Reportedly Named As Preferred Bidder For Dream Pharma